NTRB Financials

Income Statement
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026
Revenue
437.5K
+0.9%
433.4K
+8.2%
400.7K
+15.8%
346.1K
-44.4%
622.5K
Cost of Revenue
255.6K
+8.0%
236.6K
-24.1%
311.8K
+12.3%
277.6K
-40.4%
465.6K
Gross Profit
181.9K
-7.6%
196.8K
+121.3%
88.9K
+29.8%
68.5K
-56.3%
156.9K
Operating Expenses
1.1M
-26.1%
1.5M
+30.8%
1.1M
-71.9%
3.9M
+82.8%
2.2M
R&D
322.2K
+30.3%
247.3K
+31.5%
188.0K
-58.9%
457.1K
-18.7%
562.6K
SG&A
750.3K
-37.7%
1.2M
+30.6%
921.8K
-73.6%
3.5M
+118.6%
1.6M
Operating Income
-890637
+29.0%
-1254351
-22.9%
-1020915
+73.7%
-3880336
-93.7%
-2003213
EBITDA
-857311
+29.7%
-1220174
-23.9%
-985036
+74.3%
-3837280
-97.2%
-1945831
Net Income
-880561
+29.1%
-1241956
-28.3%
-968059
+75.0%
-3872367
-93.6%
-2000337
EPS (Basic)
$-0.07
+30.0%
$-0.10
-25.0%
$-0.08
+75.0%
$-0.32
+84.9%
$-2.12
EPS (Diluted)
$-0.07
+30.0%
$-0.10
-25.0%
$-0.08
+75.0%
$-0.32
+84.9%
$-2.12
Shares (Diluted)
12.2M
+0.0%
12.2M
-0.1%
12.2M
+0.9%
12.1M
+7.5%
11.2M
Nutriband (NTRB) โ€” Financials